(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl)tetrahydrofuran-3,4-diol (CAS No: 163706-58-9) is a key pharmaceutical intermediate used in the synthesis of APIs Cangrelor. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Adenosine, N-(2-(methylthio)ethyl)-2-((3,3,3-trifluoropropyl)thio)-, Cangrelor intermediate
CAS No: 163706-58-9
PubChem CID: 10600409
Mol Formula: C16H22F3N5O4S2
Mol Weight: 469.5 g/mol
Used in API: Cangrelor
IUPAC Name: (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolane-3,4-diol
API Intermediate Description: The compound (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl)tetrahydrofuran-3,4-diol appears to be a research chemical, specifically a novel purine derivative synthesized for drug discovery and research purposes. Its specific use is not in a commercially available drug but as a tool for scientists to study chemical and biological properties, likely related to cancer or other diseases that involve purine metabolism.